OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of Spironolactone in SARS-CoV-2 ARDS Patients
Güleren Yartaş Dumanlı, Olcay Dilken, Seval Ürkmez
Turkish Journal of Anaesthesiology and Reanimation (2020) Vol. 48, Iss. 3, pp. 254-255
Open Access | Times Cited: 12
Güleren Yartaş Dumanlı, Olcay Dilken, Seval Ürkmez
Turkish Journal of Anaesthesiology and Reanimation (2020) Vol. 48, Iss. 3, pp. 254-255
Open Access | Times Cited: 12
Showing 12 citing articles:
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier
Medical Hypotheses (2020) Vol. 143, pp. 110112-110112
Open Access | Times Cited: 57
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier
Medical Hypotheses (2020) Vol. 143, pp. 110112-110112
Open Access | Times Cited: 57
Covid-19 and development of heart failure: mystery and truth
Hope Onohuean, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2013-2021
Open Access | Times Cited: 56
Hope Onohuean, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2013-2021
Open Access | Times Cited: 56
Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Flavio Cadegiani, Carlos Gustavo Wambier, Andy Goren
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 49
Flavio Cadegiani, Carlos Gustavo Wambier, Andy Goren
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 49
Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation
Jonatan Barrera‐Chimal, Leslie Rocha, Isabel Amador‐Martínez, et al.
Nephrology Dialysis Transplantation (2018) Vol. 34, Iss. 5, pp. 794-801
Closed Access | Times Cited: 48
Jonatan Barrera‐Chimal, Leslie Rocha, Isabel Amador‐Martínez, et al.
Nephrology Dialysis Transplantation (2018) Vol. 34, Iss. 5, pp. 794-801
Closed Access | Times Cited: 48
Repurposing existing drugs for COVID-19: an endocrinology perspective
Flavio Cadegiani
BMC Endocrine Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Flavio Cadegiani
BMC Endocrine Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Is Spironolactone the Preferred Renin–Angiotensin–Aldosterone Inhibitor for Protection Against COVID-19?
Christopher S. Wilcox, Bertram Pitt
Journal of Cardiovascular Pharmacology (2020) Vol. 77, Iss. 3, pp. 323-331
Open Access | Times Cited: 25
Christopher S. Wilcox, Bertram Pitt
Journal of Cardiovascular Pharmacology (2020) Vol. 77, Iss. 3, pp. 323-331
Open Access | Times Cited: 25
Possible Old Drugs for Repositioning in COVID-19 Treatment: Combating Cytokine Storms from Haloperidol to Anti-interleukin Agents
Serkan Tulgar, Ali Ahişkalıoğlu, Abdulaziz Kok, et al.
Turkish Journal of Anaesthesiology and Reanimation (2020) Vol. 48, Iss. 3, pp. 256-257
Open Access | Times Cited: 6
Serkan Tulgar, Ali Ahişkalıoğlu, Abdulaziz Kok, et al.
Turkish Journal of Anaesthesiology and Reanimation (2020) Vol. 48, Iss. 3, pp. 256-257
Open Access | Times Cited: 6
ACE2 Netlas: In silico Functional Characterization and Drug-Gene Interactions of ACE2 Gene Network to Understand Its Potential Involvement in COVID-19 Susceptibility
Gita A. Pathak, Frank R. Wendt, Aranyak Goswami, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 5
Gita A. Pathak, Frank R. Wendt, Aranyak Goswami, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 5
Pengkajian Terapi COVID-19 Pada Pasien Rawat Inap Komorbid Hipertensi Terhadap Derajat Keparahan Penyakit di RSJPD Harapan Kita
Adin Hakim Kurniawan, Nanda Puspita, Tri Indriyani Meitinawati, et al.
JPSCR Journal of Pharmaceutical Science and Clinical Research (2022) Vol. 7, Iss. 2, pp. 132-132
Open Access | Times Cited: 3
Adin Hakim Kurniawan, Nanda Puspita, Tri Indriyani Meitinawati, et al.
JPSCR Journal of Pharmaceutical Science and Clinical Research (2022) Vol. 7, Iss. 2, pp. 132-132
Open Access | Times Cited: 3
Therapeutic Potentials and Candidates for COVID-19
Mina Rezghi Rami, Maryam Meskini, Nahid Rezaei Khozani, et al.
Deleted Journal (2023) Vol. 47, Iss. 4, pp. 1283-1297
Closed Access | Times Cited: 1
Mina Rezghi Rami, Maryam Meskini, Nahid Rezaei Khozani, et al.
Deleted Journal (2023) Vol. 47, Iss. 4, pp. 1283-1297
Closed Access | Times Cited: 1
To Curb the Progression of Fatal COVID-19 Course—Dream or Reality
Szymon Price, Radosław Targoński, Janusz Sadowski, et al.
Current Hypertension Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 3
Szymon Price, Radosław Targoński, Janusz Sadowski, et al.
Current Hypertension Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 3
ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility
Gita A. Pathak, Frank R. Wendt, Aranyak Goswami, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Gita A. Pathak, Frank R. Wendt, Aranyak Goswami, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
